Business Context and Reporting Period
Company: ScanSource, Inc. (SCSC)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended March 31, 2025
Business Overview: ScanSource is a leading hybrid distributor connecting devices to the cloud, operating in the United States, Canada, and Brazil. The company operates through two segments: Specialty Technology Solutions (wholesale hardware and SaaS) and Intelisys & Advisory (agency model for connectivity and cloud services).
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $704,847 | $752,599 | $2,227,924 | $2,513,696 |
| Gross Profit | $100,202 | $94,481 | $303,544 | $301,738 |
| Gross Margin % | 14.2% | 12.6% | 13.6% | 12.0% |
| Operating Income | $22,339 | $17,542 | $58,413 | $68,454 |
| Net Income | $17,431 | $12,806 | $51,458 | $60,964 |
| Diluted EPS | $0.74 | $0.50 | $2.13 | $2.41 |
| Cash & Equivalents | $146,287 | $185,460 (Jun '24) | $146,287 | $36,178 (Jun '23) |
| Operating Cash Flow (9M) | $104,704 | $316,908 | ||
| Total Debt | $138,024 | $144,056 (Jun '24) | $138,024 | $144,056 (Jun '24) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6.3% in Q3 and 11.4% for the nine months ended March 31, 2025, compared to the prior year. The decline was driven primarily by a 41.1% drop in Brazil sales (Q3) due to foreign exchange impacts and soft demand, partially offset by growth in the Intelisys & Advisory segment.
- Profitability Improvement: Despite lower sales, Net Income increased 36.2% in Q3 and Operating Income increased 27.3% in Q3. This was driven by improved gross margins (up 160 bps in Q3) and lower interest expense due to reduced revolver utilization.
- Acquisitions: The company completed two acquisitions in August 2024 (Resourcive and Advantix) with a combined purchase price of approximately $56.7 million. These contributed to higher intangible amortization expenses ($4.9M in Q3 vs $3.8M prior year).
- Restructuring: Restructuring costs of $5.4 million were incurred in the first nine months of 2025, compared to $3.9 million in the prior year period, related to cost reduction programs.
- Share Repurchases: The company repurchased approximately 719,000 shares in Q3 2025, totaling roughly $28.9 million. A new $200 million repurchase authorization was approved by the Board subsequent to the quarter end.
Guidance, Outlook, and Risks
- Outlook: Management expects the effective tax rate for fiscal year 2025 to be approximately 28.2% to 29.2%. Capital expenditures for fiscal 2025 are expected to range from $7.0 million to $9.0 million.
- Macro Risks: The company cites significant uncertainty regarding the global macroeconomic environment, including inflation, tariffs, and shifting trade relations. While they expect to pass tariff-related price increases to customers, the ultimate impact remains unpredictable.
- Contingent Consideration: The company recorded a $2.0 million expense for the change in fair value of contingent consideration related to recent acquisitions (Advantix and Resourcive) for the nine months ended March 31, 2025.
- Liquidity: The company maintains a $350 million revolving credit facility with $350.0 million available as of March 31, 2025. It remains in compliance with all financial covenants (Leverage Ratio < 3.50x; Interest Coverage Ratio > 3.00x).
Investor Verification Checklist
- Brazil Exposure: Verify the sustainability of the 41% sales decline in Brazil and the extent to which foreign exchange rates are masking organic performance.
- Acquisition Integration: Assess the performance of the newly acquired Resourcive and Advantix businesses and the impact of increased amortization on future margins.
- Working Capital Efficiency: Monitor Days Sales Outstanding (DSO), which increased slightly to 72 days, and inventory turns, which improved to 5.0x.
- Debt Covenants: Confirm continued compliance with the Leverage Ratio and Interest Coverage Ratio covenants given the sales headwinds.
- Shareholder Returns: Track the execution of the new $200 million share repurchase program approved in May 2025.